scholarly journals Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease

1996 ◽  
Vol 49 (5) ◽  
pp. 1379-1385 ◽  
Author(s):  
Robert N. Foley ◽  
Patrick S. Parfrey ◽  
John D. Harnett ◽  
Gloria M. Kent ◽  
David C. Murray ◽  
...  
Keyword(s):  
Renal Disease ◽  
End Stage Renal Disease ◽  
Morbidity And Mortality ◽  
Stage Renal Disease ◽  
End Stage

Clinical Considerations in Hemodialysis Access Intervention

2018 ◽  
pp. 594-614
Author(s):  
Eric K. Hoffer
Keyword(s):  
Renal Disease ◽  
Arteriovenous Fistula ◽  
End Stage Renal Disease ◽  
Morbidity And Mortality ◽  
Dialysis Access ◽  
Hemodialysis Access ◽  
National Kidney Foundation ◽  
Clinical Considerations ◽  
Stage Renal Disease ◽  
End Stage

Interventional radiologists developed and refined the endovascular approaches to maintenance of the permanent arteriovenous vascular accesses that are integral to the provision of hemodialysis for patients with end stage renal disease. As methods of percutaneous arteriovenous fistula creation expand the scope of IR, this chapter reviews the clinical indications and preferences pertinent to dialysis access creation with respect to National Kidney Foundation Recommendations. Accesses remain imperfect, plagued by the development of flow-limiting intimal hyperplastic stenoses, and require monitoring and maintenance to minimize complications, morbidity and mortality. The measures of dialysis access function used in the surveillance of vascular accesses that indicate potential stenosis, and the utility of pre-occlusion recanalization of these stenoses are discussed. Complications specific to dialysis access interventions are also addressed.

Postoperative Morbidity and Mortality After Elective Anterior Cervical Fusion in Patients with Chronic and End-Stage Renal Disease

2016 ◽  
Vol 95 ◽  
pp. 480-485 ◽  
Author(s):  
Rafael De la Garza Ramos ◽  
Amit Jain ◽  
Jonathan Nakhla ◽  
Rani Nasser ◽  
Varun Puvanesarajah ◽  
...  
Keyword(s):  
Renal Disease ◽  
End Stage Renal Disease ◽  
Postoperative Morbidity ◽  
Anterior Cervical Fusion ◽  
Morbidity And Mortality ◽  
Cervical Fusion ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals Risks and Benefits of Kidney Transplantation during the COVID Pandemic: Transplant or Not Transplant?

Kidney360 ◽  
2021 ◽  
pp. 10.34067/KID.0002532021
Author(s):  
Maria Ajaimy ◽  
Luz Liriano-Ward ◽  
Jay A Graham ◽  
Enver Akalin
Keyword(s):  
Renal Disease ◽  
Kidney Transplant ◽  
End Stage Renal Disease ◽  
Donor Selection ◽  
Waiting List ◽  
Morbidity And Mortality ◽  
Kidney Transplant Recipients ◽  
Risks And Benefits ◽  
Stage Renal Disease ◽  
End Stage

COVID-19 disease has significantly affected the transplant community by leading to decreased transplant activity and increased waiting list time. As expected, COVID-19 causes substantial mortality in both end-stage renal disease and kidney transplant populations. This is due to underlying chronic kidney disease and a high prevalence of comorbid conditions such as diabetes mellitus, hypertension, and cardiovascular disease in this group. Transplant programs have faced the difficult decision of weighing the risks and benefits of transplantation during the pandemic. On one hand there is a risk of COVID-19 exposure leading to infection while patients are on maximum immunosuppression. Alternatively, there are risks of delaying transplantation, which will increase waitlist-time and may lead to waitlist-associated morbidity and mortality. Cautious and thoughtful selection of both the recipient's and donor's post-transplant management is required during the pandemic to mitigate the risk of morbidity and mortality associated with COVID-19. In this review article we aimed to discuss previous publications related to clinical outcomes of COVID-19 disease in kidney transplant recipients, end-stage renal disease patients on dialysis or on the transplant waiting-list and precautions transplant centers should take in decision making for recipient and donor selection and immunosuppressive management during the pandemic. Nevertheless, transplantation in this milieu does seem to be the correct decision with a careful patient and donor selection with safeguard protocols for infection prevention. Each center should do risk assessment based on their patient's age and medical comorbidities, waitlist time, degree of sensitization, cold ischemia time, status of vaccination, and severity of pandemic in their region.

scholarly journals Prevalence of morbidity and mortality of diabetes mellitus in a rural community cohort

2021 ◽  
Vol 15 (1) ◽  
pp. 31-36
Author(s):  
M Abu Sayeed ◽  
Parvin Akter Khanam ◽  
Akhter Banu ◽  
Khandaker Abul Ahsan ◽  
Fazlul Haq
Keyword(s):  
Diabetes Mellitus ◽  
Renal Disease ◽  
Rural Community ◽  
End Stage Renal Disease ◽  
Morbidity And Mortality ◽  
Past Century ◽  
Study Cohort ◽  
Double Burden ◽  
Stage Renal Disease ◽  
End Stage

Background and objectives: The developing countries are facing the double burden of the communicable (CD) and non-communicable (NCD) diseases. The initiation of primary health care (PHC) adopted in the past century, which included sanitation and immunization, remarkably reduced the load of CDs in the least developing nations. The burden of NCDs remained the same or showed an increasing trend. Of the NCDs, diabetes has become a serious threat to human health and the related morbidity and mortalities are affecting the younger people. As a consequence, the disease complications render huge number of people to disabilities and unusual enormous health expenditures. Very few studies addressed the prevalence of complications among the diabetes patients in a rural community.  This study aimed to determine the prevalence of sequels (morbidity and mortality) among the diabetic cases eight years after the initial diagnosis of diabetes in a rural community cohort Subjects and Methods: A rural community survey in 10 villages was conducted in 1993. The survey screened 1319 (797 men, 522 women) for diabetes mellitus (DM) and impaired glucose tolerance (IGT). Those who were diagnosed DM and IGT referred to a referral center (BIRDEM) for registration. A retrospective cohort was designed in 2001. The addresses of the patients were retrieved from the BIRDEM registry. These registered patients, both survivors and non-survivors, were traced in ten villages. The survivors were investigated (anthropometry, glycemia, fundoscopy, urine protein etc.). A verbal autopsy was performed to determine the cause(s) of death in the non-survivors. Results: Of the188 registered cases, 79 were found and located (survivors 43 (54.4%, non-survivors 36 (45.6%). Of the survivors, 44.2% developed complications. The observed complications were sensory neuropathy 16.3%, CAD 9.3%, retinopathy 7% and nephropathy 4.7%. Among the non-survivors, 19.4% were found to have nephropathy leading to end-stage renal disease. Conclusions: The study cohort revealed that more than one-third of the people with diabetes died in less than ten years after being diagnosed. The cohort also revealed that diabetic nephropathy (end-stage renal disease) and dearth of dialysis facilities contributed to early death in the rural community. Among the complications, most frequent incidence was neuropathy and neuro-psychiatric disorders. Ibrahim Med. Coll. J. 2021; 15(1): 31-36

Repeated Use of Dialyzers is Safe: Long-Term Observations on Morbidity and Mortality in Patients with End-Stage Renal Disease

Nephron ◽  
1986 ◽  
Vol 42 (3) ◽  
pp. 217-223 ◽  
Author(s):  
Victor E. Pollak ◽  
Shashi Kant ◽  
Sandra L. Parnell ◽  
Nathan W. Levin
Keyword(s):  
Renal Disease ◽  
End Stage Renal Disease ◽  
Morbidity And Mortality ◽  
Repeated Use ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals Stenotrophomonas maltophilia: an emerging pathogen in dialysis units

2014 ◽  
Vol 63 (11) ◽  
pp. 1407-1410 ◽  
Author(s):  
Andreana De Mauri ◽  
Massimo Torreggiani ◽  
Doriana Chiarinotti ◽  
Stefano Andreoni ◽  
Gianlorenzo Molinari ◽  
...  
Keyword(s):  
Renal Disease ◽  
End Stage Renal Disease ◽  
Stenotrophomonas Maltophilia ◽  
Treatment Algorithm ◽  
Chronic Dialysis ◽  
Morbidity And Mortality ◽  
Emerging Pathogen ◽  
Stage Renal Disease ◽  
End Stage ◽  
Systemic Infections

Infection is an important cause of morbidity and mortality among patients with end stage renal disease. Stenotrophomonas maltophilia is an unusual yet emerging pathogen in dialysis units. We performed a systematic PubMed/Medline and Scopus review of peer-reviewed English papers on S. maltophilia infections among patients undergoing chronic dialysis, with regard to vascular accesses, systemic infections and environment contaminations. Moreover, we suggest a treatment algorithm to preserve the patient and the permanent dialysis catheters.

Sign in / Sign up

Export Citation Format

Share Document